Virometix: Anna Sumeray takes over from Arin Ghasparian
Biotech company Virometix today announced the appointment of Anna Sumeray as Chief Executive Officer. Anna Sumeray succeeds founder Arin Ghasparian, who will remain member of the Board of Directors.
Read full article »
Virometix develops and commercializes vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.
Read more